论文部分内容阅读
目的:探讨急性ST段抬高型心肌梗死治疗方法及预后。方法:随机分组就常规药物及静脉溶栓术治疗(对照组)与加用辛伐他汀治疗(观察组)临床效果进行对比。结果:观察组选取病例近期总有效率为96%,显著高于对照组72%,差异有统计学意义(P<0.05)。观察组远期非致死性心肌梗死1例,心源性死亡1例;对照组非致死性心肌梗死6例,心源性死亡7例,差异均有统计学意义(P<0.05)。结论:急性ST段抬高型心肌梗死患者在应用常规方案积极治疗的同时,加用辛伐他汀应用,可显著提高近期总有效率,改善心功能,降低心源性死亡率及非致死性心肌梗死,提高远期预后,具有非常积极的应用价值。
Objective: To investigate the treatment and prognosis of acute ST-segment elevation myocardial infarction. Methods: Randomized groups were compared on the clinical efficacy of conventional drugs and intravenous thrombolysis (control group) plus simvastatin (observation group). Results: The total effective rate of the selected cases in the observation group was 96%, which was significantly higher than that of the control group (72%), the difference was statistically significant (P <0.05). There were 1 case of long-term non-fatal myocardial infarction and 1 case of cardiac death in the observation group. There were 6 cases of non-fatal myocardial infarction and 7 cases of cardiac death in the control group. The differences were statistically significant (P <0.05). Conclusion: In patients with acute ST-segment elevation myocardial infarction, active treatment with conventional regimen and simvastatin plus can significantly improve the total effective rate, improve cardiac function, reduce the rate of cardiac death and non-fatal myocardial injury Infarction, improve long-term prognosis, has a very positive value.